Results 181 to 190 of about 10,346,027 (303)
Cloperastine suppresses osteoclastogenesis by inhibiting PGC1β‐mediated oxidative phosphorylation. Its incorporation into a ROS‐responsive, Asp8‐modified nanoplatform enhances skeletal accumulation. The resulting Clo/Asp8‐PMK‐MCs combine cloperastine‐mediated antiresorptive activity with carrier‐mediated osteogenic activity to attenuate OVX‐induced ...
Haibo Liang +16 more
wiley +1 more source
Assessing multidimensional student engagement in studio-based design learning: a traceable multimodal framework for teacher-led inquiry. [PDF]
Meng Y, Wang Z, Ruan B.
europepmc +1 more source
Lactate and H4K12la are elevated in Parkinson's disease. Mechanistically, p300‐mediated H4K12la enrichment at the HIF‐1α promoter upregulates HIF‐1α, which represses Ndufs1, impairing mitochondrial respiration and energy homeostasis in DA neurons.
Yingyao Liu +15 more
wiley +1 more source
Green mechanochemical copolymerization was developed for universal interfacial modification of Group 13 and related fillers. By leveraging Lewis acid–base coordination to anchor sulfur‐containing polymers—validated via multiscale characterization and DFT—this versatile method boosts performance across liquid fuels, thermal‐shielding materials, and ...
Chen Wang +7 more
wiley +1 more source
Is hands-on learning still necessary in the age of AI? A thematic review. [PDF]
Yu J, Liu L, Zhu Q.
europepmc +1 more source
This work presents a THz pixelated metasensor that employs loss optimization and spectral overlap for enhanced molecular vibrational fingerprint sensing. The flexible loss rate tuning through the out‐of‐plane dimension allows the device to operate in the optimal fingerprint enhancement condition.
Chenglin Yang +8 more
wiley +1 more source
Sustainable Design Reuse: Integrating Biomimicry and Parametric Thinking in Architectural Education. [PDF]
Semlali A, Tamzini S, Cazacova L.
europepmc +1 more source
EGFR mutations drive a substantial fraction of non‐small cell lung cancers (NSCLC) and are effectively targeted by tyrosine kinase inhibitors (TKIs), including osimertinib. However, resistance inevitably develops through secondary mutations and compensatory receptor activation, including the GAS6 receptor MERTK.
Suvendu Giri +28 more
wiley +1 more source

